389 related articles for article (PubMed ID: 19372225)
1. Evaluation of in vitro models for screening alkaline phosphatase-mediated bioconversion of phosphate ester prodrugs.
Yuan H; Li N; Lai Y
Drug Metab Dispos; 2009 Jul; 37(7):1443-7. PubMed ID: 19372225
[TBL] [Abstract][Full Text] [Related]
2. In vitro behavior of a phosphate ester prodrug of amprenavir in human intestinal fluids and in the Caco-2 system: illustration of intraluminal supersaturation.
Brouwers J; Tack J; Augustijns P
Int J Pharm; 2007 May; 336(2):302-9. PubMed ID: 17207947
[TBL] [Abstract][Full Text] [Related]
3. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
[TBL] [Abstract][Full Text] [Related]
4. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
5. Characterization of recombinantly expressed rat and monkey intestinal alkaline phosphatases: in vitro studies and in vivo correlations.
Subramanian M; Paruchury S; Singh Gautam S; Pratap Singh S; Arla R; Pahwa S; Jana S; Katnapally P; Yoganand V; Lakshmaiah B; Mazumder Tagore D; Ghosh K; Marathe P; Mandlekar S
Drug Metab Dispos; 2013 Jul; 41(7):1425-32. PubMed ID: 23633529
[TBL] [Abstract][Full Text] [Related]
6. Absorption of ester prodrugs in Caco-2 and rat intestine models.
He X; Sugawara M; Takekuma Y; Miyazaki K
Antimicrob Agents Chemother; 2004 Jul; 48(7):2604-9. PubMed ID: 15215116
[TBL] [Abstract][Full Text] [Related]
7. In-vitro corneal permeation of cannabinoids and their water-soluble phosphate ester prodrugs.
Juntunen J; Järvinen T; Niemi R
J Pharm Pharmacol; 2005 Sep; 57(9):1153-7. PubMed ID: 16105235
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of dendrimer prodrugs for oral drug delivery.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Int J Pharm; 2007 May; 336(1):183-90. PubMed ID: 17188439
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel system for estimating human intestinal absorption using Caco-2 cells in the absence of esterase activity.
Ohura K; Sakamoto H; Ninomiya S; Imai T
Drug Metab Dispos; 2010 Feb; 38(2):323-31. PubMed ID: 19923255
[TBL] [Abstract][Full Text] [Related]
10. Enzyme-mediated precipitation of parent drugs from their phosphate prodrugs.
Heimbach T; Oh DM; Li LY; Rodríguez-Hornedo N; Garcia G; Fleisher D
Int J Pharm; 2003 Aug; 261(1-2):81-92. PubMed ID: 12878397
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.
Mäntylä A; Garnier T; Rautio J; Nevalainen T; Vepsälainen J; Koskinen A; Croft SL; Järvinen T
J Med Chem; 2004 Jan; 47(1):188-95. PubMed ID: 14695832
[TBL] [Abstract][Full Text] [Related]
12. Mathematical models to calculate fosphenytoin concentrations in the presence of phenytoin using phenytoin immunoassays and alkaline phosphatase.
Dasgupta A; Handy BC; Datta P
Am J Clin Pathol; 2000 Jan; 113(1):87-92. PubMed ID: 10631861
[TBL] [Abstract][Full Text] [Related]
13. Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole enhance metabolic stability in vitro and in vivo.
Lorenzi PL; Landowski CP; Song X; Borysko KZ; Breitenbach JM; Kim JS; Hilfinger JM; Townsend LB; Drach JC; Amidon GL
J Pharmacol Exp Ther; 2005 Aug; 314(2):883-90. PubMed ID: 15901797
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of fluconazole after administration of fosfluconazole and fluconazole in critically ill patients.
Aoyama T; Hirata K; Hirata R; Yamazaki H; Yamamoto Y; Hayashi H; Matsumoto Y
J Clin Pharm Ther; 2012 Jun; 37(3):356-63. PubMed ID: 21883330
[TBL] [Abstract][Full Text] [Related]
15. Development and application of an ex vivo fosphenytoin nasal bioconversion/permeability evaluation method.
Antunes Viegas D; Rodrigues M; Francisco J; Falcão A; Alves G; Santos AO
Eur J Pharm Sci; 2016 Jun; 89():61-72. PubMed ID: 27106504
[TBL] [Abstract][Full Text] [Related]
16. Stereoselective and concentration-dependent polarized epithelial permeability of a series of phosphoramidate triester prodrugs of d4T: an in vitro study in Caco-2 and Madin-Darby canine kidney cell monolayers.
Siccardi D; Kandalaft LE; Gumbleton M; McGuigan C
J Pharmacol Exp Ther; 2003 Dec; 307(3):1112-9. PubMed ID: 14557377
[TBL] [Abstract][Full Text] [Related]
17. Absorption rate limit considerations for oral phosphate prodrugs.
Heimbach T; Oh DM; Li LY; Forsberg M; Savolainen J; Leppänen J; Matsunaga Y; Flynn G; Fleisher D
Pharm Res; 2003 Jun; 20(6):848-56. PubMed ID: 12817887
[TBL] [Abstract][Full Text] [Related]
18. Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugs.
Pettit GR; Lippert JW
Anticancer Drug Des; 2000 Jun; 15(3):203-16. PubMed ID: 11049088
[TBL] [Abstract][Full Text] [Related]
19. A study of the intestinal absorption of an ester-type prodrug, ME3229, in rats: active efflux transport as a cause of poor bioavailability of the active drug.
Okudaira N; Tatebayashi T; Speirs GC; Komiya I; Sugiyama Y
J Pharmacol Exp Ther; 2000 Aug; 294(2):580-7. PubMed ID: 10900235
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro and in vivo characterization of novel ethyl dioxy phosphate prodrug of propofol.
Kumpulainen H; Järvinen T; Mannila A; Leppänen J; Nevalainen T; Mäntylä A; Vepsäläinen J; Rautio J
Eur J Pharm Sci; 2008 Jul; 34(2-3):110-7. PubMed ID: 18403185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
